Gender-specific medicine is the study of how diseases differ between men and women in terms of prevention, clinical signs, therapeutic approaches, prognoses, psychological and social impact.
Medical textbooks show mostly male bodies and describe male symptoms. Female pain is often dismissed, which delays diagnoses. Women are still generally being treated as small men.
Researchers have found sex differences in every tissue and organ system in the human body, as well as in the ‘prevalence, course and severity’ of the majority of common human diseases.
When women are included in trials, they tend to be tested in the early follicular phase of their menstrual cycle, when hormone levels are at their lowest. The idea is to minimise the possible impacts oestradiol and progesterone may have on the study outcomes. Sadly, real life is not a study and those hormones will be having an impact on outcomes.
Women made up only 18% of participants in trials for endovascular occlusion devices and 32% of participants in studies on coronary stents, while women represented 90% and 92% of participants in facial wrinkle correction trials and dental device trials, respectively.
The gender data gap in medicine must be tackled asap. Join a community of researchers, medical practitioners and policy makers striving to provide medical care for male and females, customised for their biological makeup.
Other verified researchers can read and review your work. You will receive feedback and your work will be published in the next edition of the journal.
Choose a paper you are interested in and help others get published sooner by reviewing their work.
The GMFS Journal offers a platform where like minded researchers can connect and exchange ideas.
30 % of our profit goes to a fund supporting further research in the field.
Receive our first edition for free and keep in touch with us.